Immunome, Inc. · NASDAQ:IMNM

Barchas Isaac sold 100,000 Immunome, Inc. shares (Form 4)

Traded Jul 6 to Jul 7, 2026 · Filed Jul 7, 2026

From Jul 6 to Jul 7, 2026, Barchas Isaac (Director) sold 100,000 Immunome, Inc. shares at an average US$24.13 for US$2.41M under a trading plan, leaving 108,504 shares. Filed Jul 7, 2026 (Form 4).

Sold
100,000 shares
Price
US$24.13 average (US$24.11 to US$24.20)
Value
US$2.41M
Holding after
108,504 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 6, 2026Common StockSale83,094US$24.11125,410Indirect
Jul 7, 2026Common StockSale16,906US$24.20108,504Indirect

Source

View original at SEC

Related